Cargando…
Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants
AIMS/HYPOTHESIS: TCF7L2 variants are the strongest genetic risk factor for type 2 diabetes. In individuals with type 1 diabetes, these variants are associated with a higher C-peptide AUC, a lower glucose AUC during an OGTT, single autoantibody positivity near diagnosis, particularly in individuals o...
Autores principales: | Redondo, Maria J., Richardson, Sarah J., Perry, Daniel, Minard, Charles G., Carr, Alice L. J., Brusko, Todd, Kusmartseva, Irina, Pugliese, Alberto, Atkinson, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729318/ https://www.ncbi.nlm.nih.gov/pubmed/36282337 http://dx.doi.org/10.1007/s00125-022-05818-y |
Ejemplares similares
-
Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes
por: Redondo, Maria J, et al.
Publicado: (2014) -
TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes
por: Redondo, Maria J., et al.
Publicado: (2018) -
Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012) -
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
por: Redondo, Maria J., et al.
Publicado: (2018) -
The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)